Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuelle Le Page

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Brain : a Journal of Neurology|June 30, 2026
Blood cytotoxic natural killer-like CD8 + CD94+ T cells migrate to the brain and predict multiple sclerosis severityEmilie Dugast, Sita Shah, Isabel Vogel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 18, 2025
Pregnancy and birth outcomes in women with multiple sclerosis: Comparison of the RESPONSE study to the general French populationElisabeth Maillart, Fabien Rollot, Emmanuelle Leray, et al.
Multiple Sclerosis and Related Disorders|May 14, 2026
External validation and improvement of an algorithm that identifies multiple sclerosis relapses in the French national healthcare claims databaseLaure Carcaillon-Bentata, Abdelilah Abouelfath, Séverine Lignot-Maleyran, et al.
Neurology|September 25, 2024
Anti-CD20 Therapies in Drug-Naive Patients With Primary Progressive Multiple Sclerosis: A Multicenter Real-Life StudyMarion Hay, Fabien Rollot, Romain Casey, et al.
JAMA Network Open|October 11, 2021
Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated SyndromeChristine Lebrun-Frénay, Fabien Rollot, Lydiane Mondot, et al.
JAMA Neurology|August 4, 2025
Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple SclerosisAntoine Gavoille, Fabien Rollot, Romain Casey, et al.
European Journal of Neurology|May 2, 2025
Secondary progression activity monitoring in MS despite an early highly active treatment the SPAM studyMikael Cohen, Fabien Rollot, Marc Debouverie, et al.
Neurology|December 23, 2022
Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal InferenceAntoine Gavoille, Fabien Rollot, Romain Casey, et al.
Neurology|July 16, 2025
Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple SclerosisCamille Robin, Fabien Rollot, Mathilde Lefort, et al.
Brain : a Journal of Neurology|February 14, 2026
Progression independent of relapse and MRI activity and treatment strategies in multiple sclerosisFabien Rollot, Romain Casey, Anne Kerbrat, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Brain : a Journal of Neurology|June 30, 2026
Blood cytotoxic natural killer-like CD8 + CD94+ T cells migrate to the brain and predict multiple sclerosis severityEmilie Dugast, Sita Shah, Isabel Vogel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 18, 2025
Pregnancy and birth outcomes in women with multiple sclerosis: Comparison of the RESPONSE study to the general French populationElisabeth Maillart, Fabien Rollot, Emmanuelle Leray, et al.
Multiple Sclerosis and Related Disorders|May 14, 2026
External validation and improvement of an algorithm that identifies multiple sclerosis relapses in the French national healthcare claims databaseLaure Carcaillon-Bentata, Abdelilah Abouelfath, Séverine Lignot-Maleyran, et al.
Neurology|September 25, 2024
Anti-CD20 Therapies in Drug-Naive Patients With Primary Progressive Multiple Sclerosis: A Multicenter Real-Life StudyMarion Hay, Fabien Rollot, Romain Casey, et al.
JAMA Network Open|October 11, 2021
Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated SyndromeChristine Lebrun-Frénay, Fabien Rollot, Lydiane Mondot, et al.
JAMA Neurology|August 4, 2025
Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple SclerosisAntoine Gavoille, Fabien Rollot, Romain Casey, et al.
European Journal of Neurology|May 2, 2025
Secondary progression activity monitoring in MS despite an early highly active treatment the SPAM studyMikael Cohen, Fabien Rollot, Marc Debouverie, et al.
Neurology|December 23, 2022
Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal InferenceAntoine Gavoille, Fabien Rollot, Romain Casey, et al.
Neurology|July 16, 2025
Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple SclerosisCamille Robin, Fabien Rollot, Mathilde Lefort, et al.
Brain : a Journal of Neurology|February 14, 2026
Progression independent of relapse and MRI activity and treatment strategies in multiple sclerosisFabien Rollot, Romain Casey, Anne Kerbrat, et al.
Pageof 7